Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 20;36(3):380-389.
doi: 10.1021/acs.chemrestox.2c00339. Epub 2023 Feb 23.

High-Throughput Screening of ToxCast PFAS Chemical Library for Potential Inhibitors of the Human Sodium Iodide Symporter

Affiliations

High-Throughput Screening of ToxCast PFAS Chemical Library for Potential Inhibitors of the Human Sodium Iodide Symporter

Tammy E Stoker et al. Chem Res Toxicol. .

Abstract

Over the past decade, there has been increased concern for environmental chemicals that can target various sites within the hypothalamic-pituitary-thyroid axis to potentially disrupt thyroid synthesis, transport, metabolism, and/or function. One well-known thyroid target in both humans and wildlife is the sodium iodide symporter (NIS) that regulates iodide uptake into the thyroid gland, the first step of thyroid hormone synthesis. Our laboratory previously developed and validated a radioactive iodide uptake (RAIU) high-throughput assay in a stably transduced human NIS cell line (hNIS-HEK293T-EPA) to identify chemicals with potential for NIS inhibition. So far, we have tested over 2000 chemicals (US EPA's ToxCast chemical libraries PI_v2, PII, and e1K) and discovered a subset of chemicals that significantly inhibit iodide uptake in the hNIS assay. Here, we utilized this screening assay to test a set of 149 unique per- and polyfluoroalkyl substances (PFAS) (ToxCast PFAS library) for potential NIS inhibition. For this evaluation, the 149 blinded samples were screened in a tiered approach, first in an initial single-concentration (≤100 μM) RAIU assay and subsequent evaluation of the chemicals that produced ≥20% inhibition using multiconcentration (MC) response (0.001-100 μM) testing in parallel RAIU and cell viability assays. Of this set, 38 of the PFAS chemicals inhibited iodide uptake ≥20% in the MC testing with 25 displaying inhibition ≥50%. To prioritize the most potent PFAS NIS inhibitors in this set, chemicals were ranked based on outcomes of both iodide uptake and cytotoxicity and normalized to perchlorate, a known positive control. Consistent with previous findings, PFOS and PFHxS were again found to be potent NIS inhibitors, yet significant inhibition was also observed for several other screened PFAS chemicals. Although further studies are clearly warranted, this initial screening effort identifies NIS as a molecular target for potential thyroid disruption by this persistent and structurally diverse class of chemicals.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Dose response curves and ranking scores (RS) for the 21 top-ranked chemicals that displayed NIS inhibition in multi-concentration screening with a RS ≥ 50. Chemical responses (for three bioreplicates) are shown as red circles representing cytotoxicity assay results and blue triangles representing RAIU assay results. The red and blue horizontal dotted lines represent the 3bMAD threshold for cell viability and RAIU assay, respectively. Ranking scores (RS) are determined using metrics that compare the toxicity adjusted area TAA and the median-difference between cytotoxicity and iodide uptake and then were normalized as a percentage of the score for perchlorate (200). A high-ranking score indicates a higher potency without as much interference by cytotoxicity. See Table S2 for demonstrative graph on ranking score metrics/calculations.

References

    1. Boas M, Feldt-Rasmussen U, & Main KM (2012). Thyroid effects of endocrine disrupting chemicals. Mol Cell Endocrinol. 355(2), 240–248. doi:10.1016/j.mce.2011.09.005 - DOI - PubMed
    1. Murk AJ, Rijntjes E, Blaauboer BJ, Clewell R, Crofton KM, Dingemans MM, Furlow JD, Kavlock R, Köhrle J, Opitz R, Traas T, Visser TJ, Xia M, & Gutleb AC (2013). Mechanism-based testing strategy using in vitro approaches for identification of thyroid hormone disrupting chemicals. Toxicol in vitro:, 27(4), 1320–1346. doi:10.1016/j.tiv.2013.02.012 - DOI - PubMed
    1. Haddow JE, Palomaki GE, Allan WC, Williams JR, Knight GJ, Gagnon J, O’Heir CE, Mitchell ML, Hermos RJ, Waisbren SE, Faix JD, & Klein RZ (1999). Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 341(8), 549–555. doi:10.1056/NEJM199908193410801 - DOI - PubMed
    1. Zoeller RT, Tan SW, & Tyl RW (2007). General background on the hypothalamic-pituitary-thyroid (HPT) axis. Crit Rev Toxicol., 37(1-2), 11–53. doi:10.1080/10408440601123446 - DOI - PubMed
    1. Zoeller RT, & Crofton KM (2005). Mode of action: developmental thyroid hormone insufficiency—neurological abnormalities resulting from exposure to propylthiouracil. Crit Rev Toxicol, 35(8-9), 771–781. doi:10.1080/10408440591007313 - DOI - PubMed

Publication types